Synopsys, Inc. — Q1 FY2023 Form 10-Q
Business context and period. Synopsys provides electronic design automation (EDA), semiconductor intellectual property (IP), and software security and quality products and services. The quarter ended January 31, 2023 (the fiscal quarter ended January 28); comparisons are with the prior-year quarter. Effective this quarter, Synopsys reports three segments: Design Automation, Design IP, and Software Integrity.
Financial highlights
| Metric | Q1 FY2023 | Prior-year quarter | Change |
|---|---|---|---|
| Revenue | $1.361 billion | $1.270 billion | +7% |
| Gross margin | $1.077 billion; 79.1% | $1.013 billion; 79.8% | Margin down about 0.7 percentage points |
| Operating income | $255.9 million | $347.0 million | −26%; operating margin 18.8% vs. 27.3% |
| Net income attributable to Synopsys | $271.5 million | $313.7 million | −13% |
| Diluted EPS | $1.75 | $1.99 | −12% |
| Operating cash flow | $114.8 million | $155.7 million | −$40.9 million |
- Revenue mix: Time-based products revenue rose 11% to $782.3 million; upfront products revenue fell 9% to $336.7 million; maintenance and service revenue increased 25% to $242.4 million.
- Segments: Design Automation revenue was $889.8 million (+11%), Design IP $343.7 million (−4%), and Software Integrity $127.8 million (+19%). Adjusted operating margins were 39%, 34%, and 12%, respectively; Design IP’s margin declined from 43%.
- Liquidity and debt: Cash, cash equivalents and short-term investments totaled $1.302 billion at quarter-end, down from $1.566 billion at October 31, 2022. Long-term debt was $20.6 million; there were no revolver borrowings. The revolving facility was increased to $850 million and extended to December 2027.
- Capital returns: Financing cash outflow included $260.7 million of treasury-stock purchases and a $45 million equity-forward payment. $1.1 billion remained authorized for repurchases at quarter-end.
Changes, outlook and notable items
- Revenue growth reflected organic growth across most product groups and geographies. Design Automation and Software Integrity improved, while Design IP revenue and adjusted operating income declined, mainly due to timing of IP product demand and higher employee costs.
- Operating expenses increased, including R&D (+21%), sales and marketing (+17%), and G&A (+20%). The quarter included $40.9 million of restructuring charges; total charges under the plan are expected to be $40–$50 million, with completion anticipated in Q3 FY2023.
- Other income was $23.3 million versus expense of $19.8 million a year earlier, primarily reflecting a $20.2 million gain on executive deferred-compensation plan assets compared with a $19.6 million loss in the prior-year quarter.
- Management said existing liquidity is expected to meet cash requirements and the capital-return program for the next 12 months and beyond. The filing provides no specific revenue or EPS guidance. Management reported minor macroeconomic effects to date, including increased purchasing scrutiny and shorter contracts in Software Integrity, and said future effects remain uncertain.
- Risks include macroeconomic and semiconductor-market weakness, customer spending and contract timing, export controls—particularly involving China—foreign exchange exposure, competition, cybersecurity, and hardware supply constraints. Synopsys said current export restrictions were not expected to have a material business impact, but future changes could affect sales.
- The Tax Act’s requirement to capitalize and amortize R&D expenditures for U.S. tax purposes is expected to significantly increase FY2023 cash tax liabilities. The reported quarterly effective tax rate was 3.8%, primarily due to tax credits and deductions.
- Synopsys is defending some customers in Bell Semiconductor patent litigation and related ITC proceedings under its customer agreements; Synopsys is not named as a defendant or respondent in those actions. A Hungarian tax dispute remains pending, with the next hearing scheduled for April 25, 2023; the filing describes a potential $0–$34 million decrease in unrecognized tax benefits over the coming 12 months, with settlement timing and effects uncertain.
Important facts for investors to verify
- Whether Design IP revenue and margins recover as customer demand and upfront IP sales timing change.
- Whether revenue growth translates into stronger operating income and cash generation given higher operating expenses and restructuring costs.
- The realization and timing of the $6.9 billion in contracted unsatisfied or partially unsatisfied performance obligations; $1.0 billion relates to non-cancellable FSA commitments, and Synopsys cautions this balance is not necessarily indicative of future sales.
- The actual cash-tax impact of R&D capitalization and any effects from evolving U.S. or international tax rules.
- Developments in export controls, the Bell Semiconductor matters, and the Hungarian tax proceeding.
- The impact of ongoing repurchases on cash balances and share count; the quarter-end cash-and-investment balance was $1.302 billion.